Endpoints News 19. März 2026 Novo wins FDA approval for high-dose Wegovy under commissioner's voucher
Endpoints News 19. März 2026 AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans
Endpoints News 19. März 2026 Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Endpoints News 19. März 2026 Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness
Endpoints News 19. März 2026 Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest